Table 1 Summary of characteristics of included studies in the current meta-analysis.
From: Additive effects of EEG neurofeedback on medications for ADHD: a systematic review and meta-analysis
Author (year) [Ref] | Criteria | Comparison | Session | N | Duration (weeks) | Outcome | Subtype | IQ | Age (years) | Female (%) | Country |
|---|---|---|---|---|---|---|---|---|---|---|---|
Lee (2017)20 | DSM-IV-TR | EEG-NF (TBR) + Medication | 20 | 18 | 10 | 1.ADHD RS: total, inattention, and H/I 2.ADHD Diagnostic System | Inattention (41.67%) Combined (44.44%) H/I (13.89%) | 100.39 | 8.75 (6–12 years) | 25 | Korea |
Medications | 18 | ||||||||||
Tang (2014)31 | DSM-IV | EEG-NF (TBR) + MPH: 18–54 mg/d | 16 | 32 | 8 | 1.Chinese ADHD rating scale: total, inattention, and H/I 2.Attentional test: d2 test | N/A | N/A | 8.6 (7–12 years) | 45.31 | China |
MPH | 32 | ||||||||||
Li (2013)21 | DSM-IV | EEG-NF (TBR) + MPH: optimal dose (starting 5–10 mg/d, max. 60 mg/day) | 40 | 32 | N/A | ADHD RS-IV: total, inattention, and H/I | Inattention (65.6%) Combined (29.7%) H/I (4.7%) | N/A | 10.6 (7–16 years) | 15.6 | China |
MPH | 32 | ||||||||||
Duric (2017)33 | ICD-10 | EEG-NF (TBR) + MPH 1 mg/kg/d | 30 | 30 | 12 | Barkley’s Defiant Children: total, inattention, and H/I | N/A | 86.02 | 11.05 (6–18 years) | 18.03 | Norway |
MPH | 31 | ||||||||||
Wang (2007)32 | DSM-IV | EEG-NF (TBR) + MPH optimal dose (starting 5 mg/d, max. 30 mg/day) | 40 | 40 | 20 | 1.Chinese Conner's behavioral rating scale: total, inattention, and H/I 2.Integrated visual and auditory continuous performance test | Inattention (58.75%) Combined (32.5%) H/I (8.75%) | 93.685 | 9.285 (6–16 years) | 15 | China |
MPH | 40 |
